Diabetes Technology

Disentangling Fear and Hypoglycemia Metrics in Type 1 Diabetes: Insights from a 12-Month Diabetes Technology Study

By MedXY 09/09/2026

This 12-month analysis in adults with type 1 diabetes using advanced diabetes technology reveals that fear and perceived hypoglycemia frequency do not straightforwardly relate to continuous glucose monitoring metrics, highlighting complex drivers beyond glycemic data.

Diabetes & Endocrinology news Pediatrics

Navigating Ethical Challenges in Pediatric Endocrinology: Case-Based Approaches and Principles

By MedXY 08/28/2026

This article explores ethical dilemmas in pediatric endocrinology through case studies, applying the four-principle framework to guide clinicians in managing complex patient scenarios effectively and compassionately.

Diabetes & Endocrinology news Public Health

Prior Authorization Suspension Boosts Access to Diabetes Technology and Improves Glycemic Control in Underserved Populations

By MedXY 08/05/2026

Suspension of prior authorization requirements led to increased access to CGM and insulin pumps and significant HbA1c improvement in type 1 diabetes patients in a safety net clinic, highlighting benefits of reducing administrative barriers.

Diabetes & Endocrinology Internal Medicine news

Breaking the C-Peptide Barrier: New Evidence Shows Automated Insulin Delivery Benefits All Adults with Type 2 Diabetes

By MedXY 01/10/2026

A landmark study reveals that automated insulin delivery systems significantly improve blood sugar control for adults with type 2 diabetes, regardless of their C-peptide levels, challenging current insurance restrictions that limit access to life-changing technology.

Diabetes & Endocrinology news OB/GYN & Women's Health Specialties

Revolutionizing Diabetes Management in Pregnancy with Hybrid Closed-Loop Technology

By MedXY 07/29/2025

A groundbreaking trial highlights how hybrid closed-loop systems improve glycemic control for pregnant women with type 1 diabetes, offering enhanced maternal and fetal health outcomes.